Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2019 Results And Provides 2020 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Cowen Defends Bausch Health Companies (BHC); 'Add Here'
February 19, 2020 11:37 AM ESTCowen analyst Ken Cacciatore reiterated an Outperform rating and $40.00 price target on Bausch Health Companies (NYSE: BHC), saying there is no change to the thesis and investors should add here.
The analyst commented, "Q4 revs were slightly above the Street, while earnings... More
Guggenheim Says Bausch Health Companies (BHC) Sell-Off 'Overdone'
February 19, 2020 11:17 AM ESTGuggenheim analyst Dana Flanders came out to defend Bausch Health Companies (NYSE: BHC), saying the sell-off is overdone.
incremental updates unlikely to inspire near-term confidence, but sell-off overdone.The analyst reiterated a Buy rating and $36.00 price target on... More
Bausch Health Co. Inc. (BHC) Posts Q4 Adjusted EBITDA of $898 Million, Revs Beat
February 19, 2020 7:02 AM ESTBausch Health Co. Inc. (NYSE: BHC) reported Q4 Adjusted EBITDA of $898 Million. Revenue for the quarter came in at $2.28 billion versus the consensus estimate of $2.2 billion.
GUIDANCE:
Bausch Health Co. Inc. sees FY2020 revenue of $8.65-8.85 billion, versus the consensus of... More
